Residual DNA testing: enhancing efficiency and regulatory compliance
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Tackle regulatory challenges while optimizing your gene therapy QC workflows
Attend this webinar for data-rich analysis of currently available residual DNA testing kits. Through case studies discussing their application in the gene therapy field, practical insights will be shared on how to leverage these technologies to support the sensitive, accurate quantitation of host cell and plasmid DNA.
Find out how to integrate optimized residual DNA testing into real-world analytical strategies that can meet gene therapy product safety and characterization requirements.
Attend this webinar to:
- Gain clarity concerning regulations for residual DNA testing in gene therapy manufacturing
- Improve QC workflow efficiency
- Receive advice on how to successfully apply dPCR for AAV quantitation
- Learn how to meet regulators’ product safety and consistency expectations
You have registered for this webinar
SPEAKERS
You might also like
Enhancing manufacturing efficiency and quality through optimized lysis in plasmid DNA extraction
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance
Optimizing plasmid DNA purification: strategies for reliable and expandable processes
